Diagnosis and treatment of the idiopathic inflammatory myopathies
Authors:
- David J. GazeleyDGDavid J. Gazeley
- Mary E. CroninMCMary E. Cronin
Open Access
- 2 September 2011
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Musculoskeletal Disease
- Vol. 3 (6) , 315-324
Abstract
The idiopathic inflammatory myopathies (IIMs) are rare disorders with the unifying feature of proximal muscle weakness. These diseases include polymyositis(PM), dermatomyositis (DM) and inclusion body myositis (IBM) as the most common. The diagnosis is based on the finding of weakness on exam, elevated muscles enzymes, characteristic histopathology of muscle biopsies, electromyography abnormalities and rash in DM. Myositis-specific antibodies have been helpful in defining subsets of patients with different responses to treatment and prognosis. The cornerstone of therapy is corticosteroids with the addition of other immunosuppressives in severe or refractory disease or patients with intolerable side effects. IBM is particularly difficult to treat but is more slowly progressive as compared with PM or DM. There is still a great need to find more effective and less-toxic therapies.Keywords
This publication has 46 references indexed in Scilit:
- Conventional Cancer Screening versus PET/CT in Dermatomyositis/PolymyositisThe American Journal of Medicine, 2010
- Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological featuresInternational Journal of Rheumatic Diseases, 2010
- Exercise effects in patients with adult idiopathic inflammatory myopathiesCurrent Opinion in Rheumatology, 2009
- Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBMNeurology, 2008
- Pathologic Skeletal Muscle Perfusion in Patients with Myositis: Detection with Quantitative Contrast-enhanced US—Initial ResultsRadiology, 2006
- Polymyositis and dermatomyositisThe Lancet, 2003
- Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis.2002
- Risk of Cancer in Patients with Dermatomyositis or PolymyositisNew England Journal of Medicine, 1992
- Polymyositis, Dermatomyositis, and Inclusion-Body MyositisNew England Journal of Medicine, 1991
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975